IL45494A - 4-(n-(aopha-pyridyl)-n-(substituted)amino)-1-phenylalklpiperidine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

4-(n-(aopha-pyridyl)-n-(substituted)amino)-1-phenylalklpiperidine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL45494A
IL45494A IL45494A IL4549474A IL45494A IL 45494 A IL45494 A IL 45494A IL 45494 A IL45494 A IL 45494A IL 4549474 A IL4549474 A IL 4549474A IL 45494 A IL45494 A IL 45494A
Authority
IL
Israel
Prior art keywords
formula
compound
compositions
compounds
acid
Prior art date
Application number
IL45494A
Other languages
English (en)
Other versions
IL45494A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL45494A0 publication Critical patent/IL45494A0/xx
Publication of IL45494A publication Critical patent/IL45494A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL45494A 1973-08-20 1974-08-19 4-(n-(aopha-pyridyl)-n-(substituted)amino)-1-phenylalklpiperidine derivatives their preparation and pharmaceutical compositions containing them IL45494A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2341965A DE2341965C3 (de) 1973-08-20 1973-08-20 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen

Publications (2)

Publication Number Publication Date
IL45494A0 IL45494A0 (en) 1974-11-29
IL45494A true IL45494A (en) 1977-07-31

Family

ID=5890196

Family Applications (1)

Application Number Title Priority Date Filing Date
IL45494A IL45494A (en) 1973-08-20 1974-08-19 4-(n-(aopha-pyridyl)-n-(substituted)amino)-1-phenylalklpiperidine derivatives their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US3933832A (de)
JP (1) JPS5049285A (de)
AT (2) AT334901B (de)
BE (1) BE818989A (de)
BG (1) BG24669A3 (de)
CA (1) CA1041513A (de)
CH (2) CH603630A5 (de)
CS (2) CS182263B2 (de)
DD (1) DD114260A5 (de)
DE (1) DE2341965C3 (de)
DK (1) DK141097C (de)
ES (2) ES429234A1 (de)
FI (1) FI57749C (de)
FR (1) FR2241314B1 (de)
GB (1) GB1468283A (de)
HU (1) HU167563B (de)
IE (1) IE40511B1 (de)
IL (1) IL45494A (de)
NL (1) NL7410989A (de)
NO (1) NO140594C (de)
PH (1) PH11999A (de)
PL (2) PL91512B1 (de)
RO (2) RO63458A (de)
SE (1) SE402285B (de)
SU (2) SU507229A3 (de)
ZA (1) ZA745306B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191683A (en) * 1975-05-28 1980-03-04 Ciba-Geigy Corporation Derivatives of 4-aminopiperidine as stabilizers for polymers
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
DE60210944T3 (de) * 2001-02-23 2015-07-23 Merck Sharp & Dohme Corp. N-substituierte nichtaryl-heterocyclische nmda/nr2b antagonisten
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20040142013A1 (en) * 2001-07-13 2004-07-22 Flow Focusing, Inc. Implantable orthopedic surgical devices with controlled release antimicrobial component
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20060263401A1 (en) * 2001-07-13 2006-11-23 Flow Focusing, Inc. Formulation and Method for Preventing Infection
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US7592360B2 (en) * 2003-06-04 2009-09-22 Merck & Co., Inc. 3-fluoro-piperidines as NMDA/NR2B antagonists
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) * 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) * 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011414A (es) * 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Derivados de piridina como antagonistas del receptor de dopamina 2 de disociacion rapida.
ES2400710T3 (es) * 2007-04-23 2013-04-11 Janssen Pharmaceutica, N.V. Tia(dia)zoles como antagonistas del receptor de dopamina 2 de disociación rápida
SI2148873T1 (sl) * 2007-04-23 2013-01-31 Janssen Pharmaceutica, N.V. Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo
ES2398625T3 (es) * 2008-07-03 2013-03-20 Janssen Pharmaceutica N.V. 6-(1-Piperazinil)-piritazinas sustituidas como antagonistas de receptores 5-HT6
US8895562B2 (en) * 2008-07-31 2014-11-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1232147B (de) * 1961-04-13 1967-01-12 Bayer Ag Verfahren zur Herstellung von acylierten N-(Alkylaminoalkyl)-aminopyridinen
NL135583C (de) * 1961-10-10
US3141823A (en) * 1962-09-04 1964-07-21 Res Lab Dr C Janssen N V Method for producing analgesia
IL25840A (en) * 1965-07-24 1969-12-31 Bayer Ag Optically active pyridine derivatives and their production

Also Published As

Publication number Publication date
ATA651374A (de) 1976-06-15
DD114260A5 (de) 1975-07-20
BG24669A3 (bg) 1978-04-12
NL7410989A (nl) 1975-02-24
DK141097C (da) 1980-08-18
DK439974A (de) 1975-04-28
SE7410540L (de) 1975-02-21
SU504480A3 (ru) 1976-02-25
FI57749C (fi) 1980-10-10
BE818989A (fr) 1975-02-19
CH603630A5 (de) 1978-08-31
CS182263B2 (en) 1978-04-28
AT334901B (de) 1977-02-10
IE40511B1 (en) 1979-06-20
DE2341965C3 (de) 1979-01-25
RO63458A (fr) 1978-06-15
ES429234A1 (es) 1976-08-16
HU167563B (de) 1975-11-28
ATA651274A (de) 1976-06-15
NO742970L (de) 1975-03-17
FR2241314A1 (de) 1975-03-21
ES429221A1 (es) 1976-08-16
PH11999A (en) 1978-10-06
PL91512B1 (de) 1977-02-28
GB1468283A (en) 1977-03-23
NO140594B (no) 1979-06-25
RO63050A (de) 1978-05-15
SU507229A3 (ru) 1976-03-15
DE2341965B2 (de) 1978-06-01
NO140594C (no) 1979-10-03
AU7248974A (en) 1976-02-19
SE402285B (sv) 1978-06-26
CH603631A5 (de) 1978-08-31
CS181767B2 (en) 1978-03-31
IE40511L (en) 1975-02-20
ZA745306B (en) 1976-04-28
JPS5049285A (de) 1975-05-01
US3933832A (en) 1976-01-20
DK141097B (da) 1980-01-14
FI57749B (fi) 1980-06-30
CA1041513A (en) 1978-10-31
IL45494A0 (en) 1974-11-29
FR2241314B1 (de) 1977-11-10
PL91562B1 (de) 1977-03-31
DE2341965A1 (de) 1975-03-06
AT334900B (de) 1977-02-10
FI234974A7 (de) 1975-02-21

Similar Documents

Publication Publication Date Title
IL45494A (en) 4-(n-(aopha-pyridyl)-n-(substituted)amino)-1-phenylalklpiperidine derivatives their preparation and pharmaceutical compositions containing them
US7208604B2 (en) Methods for the synthesis of alfentanil, sufentanil, and remifentanil
JP3833116B2 (ja) ビフェニル誘導体、その製法及び薬剤としての使用
CA1245662A (en) Anorexigenic trifluoromethylphenyltetrahydropyridines, a process for their preparation and pharmaceutical compositions containing them
NO162818B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihyropyridiner.
EP0912550A1 (de) Sulfonamide derivatives als 5ht7 rezeptor antagoniste
WO1998056787A1 (de) 4-Phenylpiperidin-Derivate
IE54620B1 (en) 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl) pyridines
EP0674514A1 (de) Verwendung von aryloxyalkyl substituierten cyclischen aminen als calciumkanal antagonisten sowie neue akyloxyalkylpiperidinderivate
JPS6036436B2 (ja) １０‐〔ω‐（ベンゾイルピペリジニル）アルキル〕フエノチアジアジンおよびその酸付加塩ならびにそれらの製造法
JPS6046115B2 (ja) テトラヒドロピリジン及びピペリジン誘導体の製法
KR940003491B1 (ko) 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
JPS6047255B2 (ja) ２−アミノ−５−スルフアモイル−安息香酸アミドの製法
SU867304A3 (ru) Способ получени производных N-фенил-N-(4-пиперидинил)амида или их солей
US4758577A (en) 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders
KR19990081970A (ko) 중추신경계에 작용하는 약물로서 사용되는 1-피라졸-3-일-에틸-4-인돌-3-일-피페리딘
HU187572B (en) Process for preparing 1,5-diphenyl-pyrazolin-3-one derivatives
US3982001A (en) 4-(3.4-Methylene dioxy phenyl)-piperidines
US3801581A (en) Alpha-phenyl-fatty acids substituted by azacycloalkyl residues and their derivatives
US4024151A (en) 4-Phenylpiperidinyl (and 4-phenyl-tetrahydropyridinyl) alkylamino-oxoalkanoic acids
US3743735A (en) Pharmaceutical compositions containing tropanol esters of alpha-phenyl-alpha-cyclopentyl-acetic acid and methods of use
US4104398A (en) 3-Lower alkoxycyproheptadines as serotonin inhibitors
US3786059A (en) 1,2,3,6-tetrahydro-4-pyridylmethyl carboxylates
US5109006A (en) Certain pharmaceutically active 6H-imidazo[1,2-a]pyridine-5-ones
US3993762A (en) Pharmaceutical compositions containing an N-[1-(ω-phenyl-alkyl) -piperidyl-4]-N- (α-pyridyl)-carboxylic acid amide and method of use